| Literature DB >> 34089062 |
Robert B Barndt1, Mon-Juan Lee1,2,3, Nanxi Huang1, Dajun D Lu1, See-Chi Lee1, Po-Wen Du1,4, Chun-Chia Chang5, Ping-Feng B Tsai5, Yu-Siou K Huang5, Hao-Ming Chang6, Jehng-Kang Wang4, Chih-Hsin Lai7, Michael D Johnson1, Chen-Yong Lin1.
Abstract
Mutations of SPINT2, the gene encoding the integral membrane, Kunitz-type serine inhibitor HAI-2, primarily affect the intestine, while sparing many other HAI-2-expressing tissues, causing sodium loss in patients with syndromic congenital sodium diarrhea. The membrane-bound serine protease prostasin was previously identified as a HAI-2 target protease in intestinal tissues but not in the skin. In both tissues, the highly related inhibitor HAI-1 is, however, the default inhibitor for prostasin and the type 2 transmembrane serine protease matriptase. This cell-type selective functional linkage may contribute to the organ-selective damage associated with SPINT 2 mutations. To this end, the impact of HAI-2 deletion on matriptase and prostasin proteolysis was, here, compared using Caco-2 human colorectal adenocarcinoma cells and HaCaT human keratinocytes. Greatly enhanced prostasin proteolytic activity with a prolonged half-life and significant depletion of HAI-1 monomer were observed with HAI-2 loss in Caco-2 cells but not HaCaT cells. The constitutive, high level prostasin zymogen activation observed in Caco-2 cells, but not in HaCaT cells, also contributes to the excessive prostasin proteolytic activity caused by HAI-2 loss. HAI-2 deletion also caused increased matriptase zymogen activation, likely as an indirect result of increased prostasin proteolysis. This increase in activated matriptase, however, only had a negligible role in depletion of HAI-1 monomer. Our study suggests that the constitutive, high level of prostasin zymogen activation and the cell-type selective functional relationship between HAI-2 and prostasin renders Caco-2 cells more susceptible than HaCaT cells to the loss of HAI-2, causing a severe imbalance favoring prostasin proteolysis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34089062 PMCID: PMC8444455 DOI: 10.1093/hmg/ddab150
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 5.121